Cytotoxic effect and mechanism inducing cell death of α-mangostin liposomes in various human carcinoma and normal cells

Anti-Cancer Drugs

Volumn 26, Issue 8, 2015, Pages 824-834

  Benjakul, Ruthairat ^a   Kongkaneramit, Lalana ^b   Sarisuta, Narong ^c   Moongkarndi, Primchanien ^a   Müller Goymann, Christel C ^d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b SRINAKHARINWIROT UNIVERSITY   (Thailand)

^c THAMMASAT UNIVERSITY   (Thailand)

^d TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

apoptosis; cytotoxic activity; liposomes; reverse phase evaporation; mangostin

Indexed keywords

ALPHA MANGOSTIN LIPOSOME; ANTINEOPLASTIC AGENT; CHOLESTEROL; DNA FRAGMENT; LIPOSOME; PHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG; MANGOSTIN; XANTHONE DERIVATIVE;

ADULT; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CARCINOMA CELL; CELL DEATH; CELL STRUCTURE; COLON CARCINOMA; CONTROLLED STUDY; DISPERSION; DRUG CYTOTOXICITY; DRUG MECHANISM; ELECTRON MICROSCOPY; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; LIPID COMPOSITION; LUNG CARCINOMA; MTT ASSAY; PARTICLE SIZE; PHOSPHOLIPID BILAYER; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; CELL LINE; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL DEATH; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; LIPOSOMES; MAGNETIC RESONANCE SPECTROSCOPY; XANTHONES;

EID: 84938780546     PISSN: 09594973     EISSN: 14735741     Source Type: Journal    
DOI: 10.1097/CAD.0000000000000235     Document Type: Article

References (30)

1. Matsumoto K, Akao Y, Kobayashi E, Ohguchi K, Ito T, Tanaka T, et al. Induction of apoptosis by xanthones from mangosteen in human leukemia cell lines. J Nat Prod 2003; 66:1124-1127.
2. Matsumoto K, Akao Y, Yi H, Ohguchi K, Ito T, Tanaka T, et al. Preferential target is mitochondria in alpha-mangostin-induced apoptosis in human leukemia HL60 cells. Bioorg Med Chem 2004; 12:5799-5806.
3. Nabandith V, Suzui M, Morioka T, Kaneshiro T, Kinjo T, Matsumoto K, et al. Inhibitory effects of crude alpha-mangostin, a xanthone derivative, on two different categories of colon preneoplastic lesions induced by 1, 2-dimethylhydrazine in the rat. Asian Pac J Cancer Prev 2004; 5:433-438.
4. Moongkarndi P, Kosem N, Kaslungka S, Luanratana O, Pongpan N, Neungton N. Antiproliferation, antioxidation and induction of apoptosis by Garcinia mangostana (mangosteen) on SKBR3 human breast cancer cell line. J Ethnopharmacol 2004; 90:161-166.
5. Moongkarndi P, Kosem N, Luanratana O, Jongsomboonkusol S, Pongpan N. Antiproliferative activity of Thai medicinal plant extracts on human breast adenocarcinoma cell line. Fitoterapia 2004; 75:375-377.
6. Matsumoto K, Akao Y, Ohguchi K, Ito T, Tanaka T, Iinuma M, Nozawa Y. Xanthones induce cell-cycle arrest and apoptosis in human colon cancer DLD-1 cells. Bioorg Med Chem 2005; 13:6064-6069.
7. Suksamrarn S, Komutiban O, Ratananukul P, Chimnoi N, Lartpornmatulee N, Suksamrarn A. Cytotoxic prenylated xanthones from the young fruit of Garcinia mangostana. Chem Pharm Bull (Tokyo) 2006; 54:301-305.
8. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000; 65:271-284.
9. Kaneda Y. Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool. Expert Opin Drug Deliv 2010; 7:1079-1093.
10. Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 2011; 63:136-151.
11. Torchilin VP, Weissig V. Liposomes: a practical approach, 2nd ed. New York: Oxford University Press; 2003.
12. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005; 4:145-160.
13. Rojanapanthu P, Sarisuta N, Chaturon K, Kraisintu K. Physicochemical properties of amphotericin B liposomes prepared by reverse-phase evaporation method. Drug Dev Ind Pharm 2003; 29:31-37.
14. Witoonsaridsilp W, Panyarachun B, Sarisuta N, Mueller-Goymann CC. Influence of microenvironment and liposomal formulation on secondary structure and bilayer interaction of lysozyme. Colloids Surf B Biointerfaces 2010; 75:501-509.
15. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55-63.
16. Herrmann M, Lorenz HM, Voll R, Griinke M, Woith W, Kalden JR. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res 1994; 22:5506-5507.
17. Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA, Robinson JP. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem 2003; 278:8516-8525.
18. Gregoriadis G. Liposome technology: liposomes preparation and related techniques. New York: Informa Healthcare; 2007.
19. Maruyama K. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv Drug Deliv Rev 2011; 63:161-169.
20. Torchilin V. Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev 2011; 63:131-135.
21. Gregoriadis G. Liposome technology: volume II entrapment of drugs and other materials into liposomes. New York: Informa Healthcare; 2007.
22. Schuetze W, Mueller-Goymann CC. Phase transformation of a liposomal dispersion into a micellar solution induced by drug-loading. Pharm Res 1998; 15:538-543.
23. Lopes LB, Scarpa MV, Silva GV, Rodrigues DC, Santilli CV, Oliveira AG. Studies on the encapsulation of diclofenac in small unilamellar liposomes of soya phosphatidylcholine. Colloids Surf B Biointerfaces 2004; 39:151-158.
24. Khalil IA, Kogure K, Akita H, Harashima H. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol Rev 2006; 58:32-45.
25. Hillaireau H, Couvreur P, Hillaireau H, Couvreur P, Hillaireau H, Le Doan T, Couvreur P. Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol Life Sci 2009; 66:2873-2896.
26. Sugano K, Kansy M, Artursson P, Avdeef A, Bendels S, Di L, et al. Coexistence of passive and carrier-mediated processes in drug transport. Nat Rev Drug Discov 2010; 9:597-614.
27. Kuo JH, Jan MS, Chang CH, Chiu HW, Li CT. Cytotoxicity characterization of catanionic vesicles in RAW 264.7 murine macrophage-like cells. Colloids Surf B Biointerfaces 2005; 41:189-196.
28. Scheper T, Al-Rubeai M. Advances in biochemical engineering biotechnology: apoptosis. New York: Springer; 1998.
29. Mahavorasirikul W, Viyanant V, Chaijaroenkul W, Itharat A, Na-Bangchang K. Cytotoxic activity of Thai medicinal plants against human cholangiocarcinoma, laryngeal and hepatocarcinoma cells in vitro. BMC Complement Altern Med 2010; 10:55.
30. Saetung A, Itharat A, Dechsukum C, Wattanapiromsakul C, Keawpradub N, Ratanasuwan P. Cytotoxicity activity of Thai medicinal plants. Songklanakarin J Sci Technol 2005; 27:469-478.